International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(13), P. 11091 - 11091
Published: July 4, 2023
Clinical
and
epidemiological
evidence
has
recently
revealed
a
link
between
coronary
artery
disease
(CAD)
cancer.
Shared
risk
factors
common
biological
pathways
are
probably
involved
in
both
pathological
conditions.
The
aim
of
this
paper
was
to
evaluate
whether
which
conventional
novel
circulating
biomarkers
could
predict
cancer
incidence
death
patients
with
CAD.
study
included
750
CAD
patients,
who
underwent
blood
sampling
for
the
evaluation
systemic
inflammatory
indexes
(NLR
SII)
specific
oxidative
damage
(leukocyte
telomere
length
(LTL),
mitochondrial
DNA
copy
number
(mtDNAcn)).
Study
participants
were
followed
up
mean
5.4
±
1.2
years.
Sixty-seven
(8.9%)
developed
during
follow-up
time,
nineteen
(2.5%)
died
Cox
multivariable
analysis
that
age
(HR
=
1.071;
95%
CI:
1.034-1.109;
p
<
0.001),
smoking
habit
1.994;
1.140-3.488;
0.016),
obesity
1.708;
1.022-2.854;
0.041)
SII
1.002;
1.001-1.003;
0.045)
associated
incidence,
while
only
1.132;
1.052-1.219;
0.001)
predictor
death.
Patients
lung
gastrointestinal
cancers
had
significantly
higher
median
mtDNAcn
levels
than
those
without
Our
suggests
aggressive
factor
modification
suppression
chronic
inflammation
may
be
essential
preventing
patients.
Postgraduate Medicine,
Journal Year:
2024,
Volume and Issue:
136(4), P. 406 - 416
Published: May 16, 2024
This
study
sought
to
investigate
the
relationship
between
systemic
inflammatory
response
index
(SIRI)
and
bone
mineral
density
(BMD),
osteoporosis,
future
fracture
risk
in
elderly
hypertensive
patients.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(5), P. 1353 - 1353
Published: Feb. 27, 2024
Background:
Metabolic
syndrome
(MetS)
is
a
globally
increasing
pathological
condition.
Recent
research
highlighted
the
utility
of
complete
blood
count-derived
(CBC)
inflammation
indexes
to
predict
MetS
in
adults
with
obesity.
Methods:
This
study
examined
CBC-derived
(NHR,
LHR,
MHR,
PHR,
SIRI,
AISI,
and
SII)
231
severe
obesity
(88
males,
143
females;
age:
52.3
[36.4–63.3]
years),
divided
based
on
presence
(MetS+)
or
absence
(MetS-)
MetS.
The
relationships
between
cardiometabolic
risk
biomarkers
HOMA-IR,
TG/HDL-C,
non-HDL-C
were
also
evaluated.
Results:
Individuals
metabolic
had
significantly
higher
values
NHR,
SIRI
than
those
without
(MHR
NHR:
p
<
0.0001;
LHR:
=
0.001;
PHR:
0.011;
SIRI:
0.021).
These
positively
correlated
degree
severity.
Logistic
regression
0.000;
0.002;
0.022;
0.040)
ROC
analysis
(MHR:
AUC
0.6604;
0.6343;
0.6741;
0.6054;
0.5955)
confirmed
predictive
potential
for
individuals
HOMA-IR
(MHR,
0.000)
TG/HDL-C
NHR
0.006).
Conclusions:
In
conclusion,
this
validates
predicting
these
factors
can
enable
clinicians
better
grade
associated
Metabolic
syndrome
(MetS)
is
a
global
public
health
problem
that
significantly
impacts
human
and
quality
of
life.
The
relationship
between
MetS
the
C-reactive
protein-albumin-lymphocyte
(CALLY)
index
uncertain.
This
study
analyzed
data
7,534
individuals
from
National
Health
Nutrition
Examination
Survey
cycles
(2003-2010
cycles).
Weighted
logistic
regression
weighted
restricted
cubic
spline
(RCS)
curve
analyses
were
used
to
identify
relationships
CALLY
MetS,
as
well
its
components.
Of
participants,
2,086
diagnosed
with
MetS.
estimated
prevalence
decreased
an
increase
in
(P
<
0.001).
Multivariable
analysis
showed
odds
ratio
was
0.25
(95%
confidence
interval
0.20-0.32,
P
0.001)
highest
quartile
compared
lowest
after
adjusting
for
confounding
variables.
RCS
revealed
non-linear
or
inverse
risk.
might
be
valuable
identifying
who
are
at
high
risk
Not
applicable.
Lipids in Health and Disease,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Aug. 10, 2024
Obesity
is
characterized
by
a
chronic
low-grade
inflammatory
condition.
Two
emerging
biomarkers,
the
systemic
immune-inflammation
index
(SII)
and
inflammation
response
(SIRI),
have
gained
attention.
However,
relationships
between
obesity
SII/SRI
remain
unclear.
BMC Geriatrics,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 15, 2024
Abstract
Background
Metabolic
syndrome
(MetS)
is
a
pathological
condition
characterized
by
the
abnormal
clustering
of
several
metabolic
components
and
has
become
major
public
health
concern.
We
aim
to
investigate
potential
link
Systemic
immunity-inflammation
index
(SII)
on
MetS
its
components.
Methods
result
Weighted
multivariable
logistic
regression
was
conducted
assess
relationship
between
SII
Restricted
cubic
spline
(RCS)
model
threshold
effect
analysis
were
also
performed.
A
total
6,999
U.S.
adults
enrolled.
Multivariate
found
that
positively
associated
with
(OR
=
1.18;95CI%:1.07–1.30)
hypertension
1.22;
95CI%:1.12–1.34)
in
dose-dependent
manner.
When
converted
into
categorical
variable,
risk
increased
36%
53%
highest
quantile
SIIs.
The
RCS
confirmed
linear
associations
MetS,
as
well
non-linear
association
certain
including
hypertension,
hyperglycemia,
low
HDL,
hyperlipidemia.
Meanwhile,
presents
J-shaped
curve
8.27,
above
which
increases.
Furthermore,
age,
sex,
body
mass
(BMI),
race
not
significantly
this
positive
based
subgroup
analyses
interaction
tests(
p
for
>
0.05).
Conclusions
present
study
indicated
there
higher
an
adults.
However,
further
prospective
cohort
studies
are
required
establish
causal
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 5, 2024
Background
and
Objective
Previous
research
suggested
a
relationship
between
the
Systemic
Immune-Inflammation
Index
(SII)
multiple
adverse
health
conditions.
However,
role
of
SII
in
prediabetes
insulin
resistance
(IR)
remains
poorly
understood.
Therefore,
this
study
aims
to
explore
potential
IR,
providing
data
support
for
effective
diabetes
prevention
by
reducing
systemic
inflammation.
Methods
Linear
regression
models
were
used
assess
correlation
continuous
risk
markers
type
2
(T2D).
Subsequently,
multivariate
logistic
subgroup
analyses
employed
evaluate
association
tertiles
controlling
various
confounding
factors.
Finally,
restricted
cubic
spline
graphs
analyze
nonlinear
IR
prediabetes.
Results
After
confounders,
was
positively
correlated
with
fasting
blood
glucose
(FBG)
(β:
0.100;
95%
CI:
0.040
0.160),
serum
(FSI)
1.042;
0.200
1.885),
homeostasis
model
assessment
(HOMA-IR)
0.273;
0.022
0.523).
Compared
participants
lower
SII,
those
highest
tertile
had
increased
odds
(OR:
1.17;
1.02-1.34;
p
trend
<
0.05)
1.35;
1.18
1.51;
trend<0.001).
Conclusions
Our
results
demonstrate
an
elevated
levels
both
prediabetes,
indicating
as
straightforward
cost-effective
method
identifying
individuals
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(11), P. 2961 - 2961
Published: Nov. 2, 2023
Metabolic
syndrome
(MetS)
in
the
pediatric
population
has
been
reported
many
studies
to
be
associated
with
an
inflammatory
response.
However,
our
knowledge,
there
is
no
definitive
conclusion
form
of
a
meta-analysis.
The
issue
we
aimed
address
whether
C-reactive
protein
(CRP)
trustworthy
marker
detecting
inflammation
children
and
adolescents
MetS.
We
systematically
searched
PubMed,
MEDLINE,
Cochrane
Central
Register
Controlled
Trials,
ISI
Web
Science,
SCOPUS
until
31
June
2023
for
involving
MetS
where
hsCRP
or
CRP
were
measured.
After
screening
process,
identified
24
full-text
articles
that
compared
930
patients
either
healthy
(n
=
3782)
obese
1658)
controls.
risk
bias
included
was
assessed
using
Begg’s
rank
correlation
test
Egger’s
regression
test.
Statistical
analysis
carried
out
based
on
pooled
mean
differences
(MDs)
95%
CI.
Data
showed
higher
levels
than
those
controls
(MD
1.28,
CI:
(0.49–2.08),
p
0.002)
0.88,
(0.38–1.39),
0.0006).
conventional
methods
found
more
accurate
differentiating
between
obesity
MetS,
0.60,
(−0.08–1.28),
0.08).
No
assessed.
In
conclusion,
reliable
from
ones.
On
other
hand,
it
did
not
prove
very
distinguishing
who
had
obese.
There
should
research
performed
this
field.
JAAD International,
Journal Year:
2024,
Volume and Issue:
15, P. 170 - 178
Published: March 15, 2024
BackgroundBiomarkers
associated
with
disease
severity
and
comorbid
metabolic
syndrome
(MetS)
in
patients
hidradenitis
suppurativa
(HS)
are
lacking.ObjectiveTo
identify
biomarkers
MetS
HS.MethodsData
on
hospital
outpatients
HS
were
obtained
through
clinical
examination
interviews.
Indicators
of
systemic
inflammation;
C-reactive
protein
(CRP),
erythrocyte
sedimentation-rate
(ESR),
neutrophil/lymphocyte-ratio
(NLR),
platelet/lymphocyte-ratio
(PLR),
monocyte/lymphocyte-ratio
(MLR),
platelet/neutrophil-ratio
(PNR),
pan-immune-inflammation-value
(PIV),
systemic-immune-inflammatory-index
(SII),
calculated
from
blood
samples.ResultsSeven
hundred
included;
those
444
(63.4%)
256
(36.6%)
female
male,
respectively,
a
median
age
38.3
years
(IQR
=
27.9-51.0).
Increasing
CRP,
ESR,
NLR,
PIV,
SII
(P
<
.001)
significantly
increasing
Hurley-stage
international
score
system
4
(IHS4)-score
adjusted
analysis.
A
doubling
CRP
(OR
1.59
(1.36-1.85),
P
.001),
ESR
1.39
(1.17-1.66),
PIV
1.41
(1.12-1.77)
.002)
was
the
best
estimator
for
severe
IHS4-score
(AUC
0.72
(0.66-0.77),
Hurley
III
0.79
(0.73-0.85),
whereas
0.67
(0.62-0.72),
.001).LimitationsPatients
setting
tend
to
have
more
disease.ConclusionBiomarkers
like
measuring
inflammation
HS.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(7), P. 2120 - 2120
Published: April 5, 2024
Background:
Childhood
obesity
is
a
globally
increasing
pathological
condition
leading
to
long-term
health
issues
such
as
cardiovascular
diseases
and
metabolic
syndrome
(MetS).
This
study
aimed
determine
the
clinical
value
of
Complete
Blood
Count-derived
inflammation
indexes
Monocyte/HDL-C
ratio
(MHR),
Lymphocyte/HDL-C
(LHR),
Neutrophil/HDL-C
(NHR),
System
Inflammation
Response
Index
(SIRI)
predict
presence
its
association
with
risk
markers
(HOMA-IR,
TG/HDL-C,
non-HDL-C)
in
children
adolescents
obesity.
Methods:
The
included
total
552
children/adolescents
severe
(BMI:
36.4
[32.7–40.7]
kg/m2;
219
males,
333
females;
age:
14.8
[12.9−16.3]
years),
who
were
further
subdivided
based
on
or
absence
(MetS+
MetS
respectively).
Results:
MHR,
LHR,
NHR
(p
<
0.0001),
but
not
SIRI
=
0.524),
significantly
higher
MetS+
compared
MetS−
subgroup,
showing
positive
correlation
degree
severity
0.0001).
Furthermore,
positively
associated
cardiometabolic
biomarkers
(HOMA-IR:
MHR
p
0.000,
LHR
0.001,
0.0001;
TG/HDL-C:
0.000;
non-HDL-C:
0.0001,
0.000).
Finally,
ROC
curve
analysis
demonstrated
that
among
analyzed
indexes,
only
had
diagnostic
distinguishing
patients
(MHR:
AUC
0.7045;
LHR:
0.7205;
NHR:
0.6934;
Conclusions:
In
conclusion,
index,
can
be
considered
useful
tools
for
pediatricians
assess
develop
multidisciplinary
intervention
strategies
counteract
widespread
disease.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 4, 2024
Systemic
immune-inflammation
index
(SII),
a
novel
inflammatory
marker,
has
been
reported
to
be
associated
with
diabetic
kidney
disease
(DKD)
in
the
U.S.,
however,
such
close
relationship
DKD
other
countries,
including
China,
not
never
determined.
We
aimed
explore
association
between
SII
and
Chinese
population.
A
total
of
1922
hospitalized
patients
type
2
diabetes
mellitus
(T2DM)
included
this
cross-sectional
study
were
divided
into
three
groups
based
on
estimated
glomerular
filtration
rate
(eGFR)
urinary
albumin-to-creatinine
ratio
(ACR):
non-DKD
group,
stages
1-2
Alb
DKD-non-Alb+DKD
stage
3
group.
The
possible
was
investigated
by
correlation
multivariate
logistic
regression
analysis,
receiver-operating
characteristic
(ROC)
curves
analysis.
Moving
from
group
level
gradually
increased
(P
for
trend
<0.01).
Partial
analysis
revealed
that
positively
ACR
prevalence
DKD,
negatively
eGFR
(all
P<0.01).
Multivariate
showed
remained
independently
significantly
presence
after
adjustment
all
confounding
factors
[(odds
(OR),
2.735;
95%
confidence
interval
(CI),
1.840-4.063;
P
<
0.01)].
Moreover,
compared
subjects
lowest
quartile
(Q1),
fully
adjusted
OR
1.060
(95%
CI
0.773-1.455)
Q2,
1.167
0.995-1.368)
Q3,
1.266
1.129-1.420)
highest
(Q4)
Similar
results
observed
or
DKD-non-
Alb+DKD
among
quartiles.
Last,
ROC
best
cutoff
values
predict
1-
2,
DKD-non-Alb+
609.85
(sensitivity:
48.3%;
specificity:
72.8%),
601.71
43.9%;
72.3%),
589.27
61.1%;
71.1%),
respectively.
Higher
is
an
risk
severity
might
promising
biomarker
its
distinct
phenotypes